Results 41 to 50 of about 1,463,832 (396)
Frontiers in Oncology, 2021 ObjectiveAnti-EGFR Targeted agents were found to be capable of modulating the antitumor immunity in head and neck cancer and become more and more frequently used in the treatment of nasopharyngeal carcinoma(NPC).
Zi-Kun Yu +11 more
doaj +1 more source
Guidelines for radiotherapy of nasopharyngeal carcinoma
Precision Radiation Oncology, 2021 With the extensive application of intensity‐modulated conformal radiotherapy and the deepening of the concept of comprehensive treatment, the therapeutic effect of nasopharyngeal carcinoma and the quality of life of patients have been significantly ...
Rensheng Wang, Min Kang
semanticscholar +1 more source
Journal of Experimental & Clinical Cancer Research, 2018 Background Distant metastasis is the major cause of treatment failure in patients with nasopharyngeal carcinoma (NPC). Although several biomarkers correlate with metastasis and prognosis, the molecular mechanisms of NPC development and progression remain
Wen-Ze Qiu +13 more
doaj +1 more source
Limited recurrence distance of glioblastoma under modern radiotherapy era
BMC Cancer, 2021 Background The optimal treatment volume for Glioblastoma multiforme (GBM) is still a subject of debate worldwide. The current study was aimed to determine the distances between recurring tumors and the edge of primary lesions, and thereby provide ...
Ziwei Tu +5 more
doaj +1 more source
Focus on nasopharyngeal carcinoma [PDF]
Cancer Cell, 2004 Support from the Hong Kong Research Grant Council (CUHK 4301/99M; 4071/02M; 4067/02M; 410/03M; and HKUST 2/03C) and the Kadoorie Charitable Foundation is gratefully acknowledged.
Kwok Wai Lo, Ka Fai To, Dolly P. Huang
openaire +3 more sources
Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
Frontiers in Oncology, 2020 Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV) infection in regions in which it is endemic, including Southern China and Southeast Asia. The high mortality rates of NPC patients with advanced and recurrent disease
P. Hau +6 more
semanticscholar +1 more source
, 2018 Mucosal nasopharyngeal melanoma is a rare head and neck melanoma. Prognosis is poor (5-year overall survival rate of 10–30%) with high rates of metastases and local recurrence. Head and neck mucosal melanoma represents 0.8–3.7% of all melanomas and 0.03%
Calvieri, Stefano +4 more
core +1 more source
Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
Signal Transduction and Targeted Therapy, 2020 Nasopharyngeal carcinoma (NPC) is a malignant epithelial carcinoma of the head and neck region which mainly distributes in southern China and Southeast Asia and has a crucial association with the Epstein–Barr virus.
Yuanbo Kang +8 more
semanticscholar +1 more source
Exosomes in Nasopharyngeal Carcinoma [PDF]
Journal of Cancer, 2018 Exosomes are nanosized (30-100nm) membrane microvesicles secreted through a complex cellular process. Exosomes contain a variety of bioactive molecules, such as proteins, microRNAs(miRNAs or miRs) and long non-coding RNAs (lncRNAs), playing an important role in the cell-to-cell substance transportation and signal transduction.
Linda Oyang +11 more
openaire +2 more sources
Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital. [PDF]
, 2020 Objective:Treatment delays and suboptimal adherence to posttreatment surveillance may adversely affect head and neck cancer (HNC) outcomes. Such challenges can be exacerbated in safety-net settings that struggle with limited resources and serve a ...
Brodie, Shauna +7 more
core +1 more source